| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 01/02/2002 | EP1167366A1 Amine derivatives |
| 01/02/2002 | EP1165557A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
| 01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
| 01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
| 01/02/2002 | EP1165545A1 Novel compounds |
| 01/02/2002 | EP1165528A1 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
| 01/02/2002 | EP1165510A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
| 01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
| 01/02/2002 | EP1165496A1 Substituted aniline compounds |
| 01/02/2002 | EP1165083A2 Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites |
| 01/02/2002 | EP1165067A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones |
| 01/02/2002 | EP1135151A4 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 01/02/2002 | EP0912553B1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/02/2002 | EP0835256B1 Microbicidal benzotriazoles |
| 01/02/2002 | EP0745074B1 4-amino derivatives of mycophenolic acid with immunosuppressant activity |
| 01/02/2002 | CN1329611A Phenylacetic acid heterocyclyl amides having an insecticidal effect |
| 01/02/2002 | CN1329609A Tetrahydrobenza epine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents) |
| 01/02/2002 | CN1329597A Pyridinium derivatives for treatment of diabetic and aging-related vascular complications |
| 01/02/2002 | CN1329596A Picolinamide derivatives and pest controllers containing same as active ingredient |
| 01/02/2002 | CN1329493A Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 01/02/2002 | CN1329002A Intermediate product for preparing aralkyl and aryl alkylene heterocyclic lactam and imide |
| 01/01/2002 | US6335460 Treating retroviral infections, including human immunodeficiency virus, and aids |
| 01/01/2002 | US6335357 1-aryl-3-cyano-5-(het)arylalkylaminopyrazole derivatives; insecticides for agriculture and horticulture |
| 01/01/2002 | US6335353 3-hydroxypyridin-4-one derivative; iron deficiency anemia and thalassemia treatment |
| 01/01/2002 | US6335327 1-benzazepine derivatives; agonists or antagonists of vasopressin and/or oxytocin |
| 01/01/2002 | US6335325 Crop protection |
| 01/01/2002 | CA2087859C Benzopyran derivatives |
| 01/01/2002 | CA2056799C 1,4-dihydropyridine derivatives and methods of producing the same |
| 01/01/2002 | CA2029105C Halogenated sulphonylaminocarbonyltriazolinones |
| 12/27/2001 | WO2001098298A1 Indole derivatives useful for the treatment of cns disorders |
| 12/27/2001 | WO2001098293A1 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 12/27/2001 | WO2001098291A2 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | WO2001098282A1 Benzoxazepinones and their use as squalene synthase inhibitors |
| 12/27/2001 | WO2001098277A2 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 12/27/2001 | WO2001098272A1 Novel compounds |
| 12/27/2001 | WO2001098270A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098269A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001098268A2 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | WO2001097787A2 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | WO2001097786A2 Benzothiazole derivatives |
| 12/27/2001 | US20010056191 Hydantoin-containing glucokinase activators |
| 12/27/2001 | US20010056123 Benzamidine derivatives |
| 12/27/2001 | US20010056113 Methods for the inhibition of angiogenesis with 6-amino EM-12 |
| 12/27/2001 | US20010056095 Salts of zopolrestat |
| 12/27/2001 | CA2413878A1 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat vcam-1 mediated disorders |
| 12/27/2001 | CA2413429A1 Benzoxazepinones and their use as squalene synthase inhibitors |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413277A1 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl) |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412141A1 Indole derivatives useful for the treatment of cns disorders |
| 12/27/2001 | CA2411255A1 Novel compounds |
| 12/26/2001 | CN1328550A Oxazole compounds as prostaglandin E2 agonists or antagonists |
| 12/26/2001 | CN1328546A Pyrrolidines as inhibitors of neuraminidases |
| 12/26/2001 | CN1328456A Use of thiazolidinediones derivatives for preventing uterine contractions in premature labour or lactation |
| 12/26/2001 | CN1328455A Use of N-substituted azabicycloalkane derivatives for treating diseases of central nervous system |
| 12/26/2001 | CN1327982A Process for preparing 2-chloro-thiazole compound |
| 12/26/2001 | CN1327978A Oxime additives and its use as fungicide |
| 12/25/2001 | US6333425 Ionic compounds derived from malononitrile in which anionic charge is delocalized; excellent properties of solubility and dissociation |
| 12/25/2001 | US6333344 Prolines as antimicrobial agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333340 Sulfonamides with oxo, ester or amide groups for vision defects and cognition activators |
| 12/25/2001 | US6333338 Anticoagulants, cardiovascular disorders |
| 12/25/2001 | US6333325 Method of treating cytokine mediated diseases or conditions |
| 12/25/2001 | US6333324 For therapy and prophylaxis of matrix metalloproteinases (mmp) or tumor necrosis factor .alpha. (tnf.alpha.), mediated diseases |
| 12/25/2001 | US6333323 Indole derivatives with antiviral activity |
| 12/25/2001 | US6333322 Nitrogen-containing tricyclic compounds and drugs containing the same |
| 12/25/2001 | US6333296 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them |
| 12/25/2001 | CA2049231C Analytical method using tetrazolium salt indicators having a reflectance plateau |
| 12/25/2001 | CA2032602C 4-carbonyl-substituted coumarin compound |
| 12/20/2001 | WO2001096874A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096333A1 Hetaryl-substituted heterocycles |
| 12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096308A1 1,2-dihydropyridine compounds, process for preparation of the same and use thereof |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096304A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096303A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096297A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | WO2001096296A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096295A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | WO2001095911A1 Protease inhibitors |
| 12/20/2001 | WO2001087838A8 Cyclohexane derivatives and their use as therapeutic agents |
| 12/20/2001 | WO2001074788A8 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 12/20/2001 | WO2001040223A3 Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 12/20/2001 | WO2001016108A3 Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 12/20/2001 | US20010053851 Antidiabetic agents |
| 12/20/2001 | US20010053785 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 12/20/2001 | DE10029077A1 New heterocyclic-substituted thiazole derivatives, useful as total or selective herbicides, insecticides, acaricides, nematocides, ectoparasiticides or antifouling agents |
| 12/20/2001 | CA2719176A1 2-cyanopyrrolidine derivatives and their use as medicaments |
| 12/20/2001 | CA2412720A1 Method for identifying compounds with anti-herpes activity |
| 12/20/2001 | CA2412618A1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 12/20/2001 | CA2412353A1 Protease inhibitors |